rs121909374
|
|
|
0.800 |
GeneticVariation |
UNIPROT |
Familial hypertrophic cardiomyopathy associated with a new mutation in gene MYBPC3.
|
28265379 |
2017 |
rs121909374
|
|
|
0.800 |
GeneticVariation |
UNIPROT |
Recommendations for reporting of secondary findings in clinical exome and genome sequencing, 2016 update (ACMG SF v2.0): a policy statement of the American College of Medical Genetics and Genomics.
|
27854360 |
2017 |
rs121909375
|
|
|
0.800 |
GeneticVariation |
UNIPROT |
Recommendations for reporting of secondary findings in clinical exome and genome sequencing, 2016 update (ACMG SF v2.0): a policy statement of the American College of Medical Genetics and Genomics.
|
27854360 |
2017 |
rs121909375
|
|
|
0.800 |
GeneticVariation |
UNIPROT |
Familial hypertrophic cardiomyopathy associated with a new mutation in gene MYBPC3.
|
28265379 |
2017 |
rs199865688
|
|
|
0.800 |
GeneticVariation |
UNIPROT |
Recommendations for reporting of secondary findings in clinical exome and genome sequencing, 2016 update (ACMG SF v2.0): a policy statement of the American College of Medical Genetics and Genomics.
|
27854360 |
2017 |
rs199865688
|
|
|
0.800 |
GeneticVariation |
UNIPROT |
Familial hypertrophic cardiomyopathy associated with a new mutation in gene MYBPC3.
|
28265379 |
2017 |
rs36211723
|
|
|
0.800 |
GeneticVariation |
UNIPROT |
Familial hypertrophic cardiomyopathy associated with a new mutation in gene MYBPC3.
|
28265379 |
2017 |
rs36211723
|
|
|
0.800 |
GeneticVariation |
UNIPROT |
Recommendations for reporting of secondary findings in clinical exome and genome sequencing, 2016 update (ACMG SF v2.0): a policy statement of the American College of Medical Genetics and Genomics.
|
27854360 |
2017 |
rs375675796
|
|
|
0.800 |
GeneticVariation |
UNIPROT |
Recommendations for reporting of secondary findings in clinical exome and genome sequencing, 2016 update (ACMG SF v2.0): a policy statement of the American College of Medical Genetics and Genomics.
|
27854360 |
2017 |
rs375882485
|
|
|
0.800 |
GeneticVariation |
UNIPROT |
Familial hypertrophic cardiomyopathy associated with a new mutation in gene MYBPC3.
|
28265379 |
2017 |
rs397514752
|
|
|
0.800 |
GeneticVariation |
UNIPROT |
Familial hypertrophic cardiomyopathy associated with a new mutation in gene MYBPC3.
|
28265379 |
2017 |
rs397514752
|
|
|
0.800 |
GeneticVariation |
UNIPROT |
Recommendations for reporting of secondary findings in clinical exome and genome sequencing, 2016 update (ACMG SF v2.0): a policy statement of the American College of Medical Genetics and Genomics.
|
27854360 |
2017 |
rs397515907
|
|
|
0.800 |
GeneticVariation |
UNIPROT |
Familial hypertrophic cardiomyopathy associated with a new mutation in gene MYBPC3.
|
28265379 |
2017 |
rs397516053
|
|
|
0.800 |
GeneticVariation |
UNIPROT |
Familial hypertrophic cardiomyopathy associated with a new mutation in gene MYBPC3.
|
28265379 |
2017 |
rs397516053
|
|
|
0.800 |
GeneticVariation |
UNIPROT |
Recommendations for reporting of secondary findings in clinical exome and genome sequencing, 2016 update (ACMG SF v2.0): a policy statement of the American College of Medical Genetics and Genomics.
|
27854360 |
2017 |
rs397516074
|
|
|
0.800 |
GeneticVariation |
UNIPROT |
Recommendations for reporting of secondary findings in clinical exome and genome sequencing, 2016 update (ACMG SF v2.0): a policy statement of the American College of Medical Genetics and Genomics.
|
27854360 |
2017 |
rs397516074
|
|
|
0.800 |
GeneticVariation |
UNIPROT |
Familial hypertrophic cardiomyopathy associated with a new mutation in gene MYBPC3.
|
28265379 |
2017 |
rs573916965
|
|
|
0.800 |
GeneticVariation |
UNIPROT |
Recommendations for reporting of secondary findings in clinical exome and genome sequencing, 2016 update (ACMG SF v2.0): a policy statement of the American College of Medical Genetics and Genomics.
|
27854360 |
2017 |
rs573916965
|
|
|
0.800 |
GeneticVariation |
UNIPROT |
Familial hypertrophic cardiomyopathy associated with a new mutation in gene MYBPC3.
|
28265379 |
2017 |
rs121909374
|
|
|
0.800 |
GeneticVariation |
UNIPROT |
ACMG policy statement: updated recommendations regarding analysis and reporting of secondary findings in clinical genome-scale sequencing.
|
25356965 |
2015 |
rs121909375
|
|
|
0.800 |
GeneticVariation |
UNIPROT |
ACMG policy statement: updated recommendations regarding analysis and reporting of secondary findings in clinical genome-scale sequencing.
|
25356965 |
2015 |
rs199865688
|
|
|
0.800 |
GeneticVariation |
UNIPROT |
ACMG policy statement: updated recommendations regarding analysis and reporting of secondary findings in clinical genome-scale sequencing.
|
25356965 |
2015 |
rs36211723
|
|
|
0.800 |
GeneticVariation |
UNIPROT |
ACMG policy statement: updated recommendations regarding analysis and reporting of secondary findings in clinical genome-scale sequencing.
|
25356965 |
2015 |
rs375675796
|
|
|
0.800 |
GeneticVariation |
UNIPROT |
ACMG policy statement: updated recommendations regarding analysis and reporting of secondary findings in clinical genome-scale sequencing.
|
25356965 |
2015 |
rs397514752
|
|
|
0.800 |
GeneticVariation |
UNIPROT |
ACMG policy statement: updated recommendations regarding analysis and reporting of secondary findings in clinical genome-scale sequencing.
|
25356965 |
2015 |